Opinions & Features

Have you ever wondered how our society values innovation, how it rewards breakthrough discoveries? Most people say that it’s the price we place on new drugs that show how much we value the breakthrough.[...]

Steve Brozak, president and managing director at WBB Securities, wants to see how new technology platforms and novel ideas fit into tomorrow's healthcare system, which he believes will be unsustainable without therapies that work more[...]

“Now is the winter of our discontent” was how Shakespeare characterized the despair of King Richard III of England. If Shakespeare was writing about the desperation of big pharma today, he would probably just[...]

The amount of real time media coverage two American Ebola patients have received has been extraordinary.

After two days of Federal Reserve Chair Janet Yellen's sometimes heated testimony before Congress, we can be sure of two things.

At 4PM ET, the German soccer team will face Brazil in The World Cup semi-finals.

On June 15, Medtronic, Inc. announced its proposed acquisition of Covidien plc for $42.9 billion in cash and stock.

Business is war and nothing is more illustrative of that point than a healthy cycle of M&A activity.

Yesterday in a move that returned attention to healthcare takeovers, Bill Ackman, CEO of the hedge fund Pershing Square Capital, announced a bold and unusual move by partnering with pharmaceutical company, Valeant Pharmaceuticals International, Inc.[...]

For today, the buzz surrounding Carl Icahn derives from his initiative to separate PayPal from eBay. More frequently, people tend to equate Icahn with his investment strategy; including his activism in Apple and significant[...]